Trial Profile
A Phase III Clinical Study of NPC-11 in the Treatment of Apnea of Prematurity. - Investigation of Safety, Efficacy and Pharmacokinetics of Caffeine Citrate -
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Apr 2018
Price :
$35
*
At a glance
- Drugs Caffeine citrate (Primary) ; Caffeine citrate (Primary)
- Indications Apnoea
- Focus Therapeutic Use
- Sponsors Nobelpharma
- 18 Apr 2014 New trial record